New Test Helps Determine Risk of Deadly Disease
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Covid 19 |
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Cancer |
Next-generation cancer strategies rely on next-generation gene sequencing (NGS), which paves the way for new tools to detect mutations.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Covid 19 |
Roche and its subsidiary TIB Molbiol developed a COVID PCR test that detects and differentiates the latest variant of concern, XBB.1.5.
Read MorePosted by Andy Lundin | Jan 31, 2023 | Diagnostic Technologies |
Arima Genomics announced an agreement with Protean BioDiagnostics to make its next-generation sequencing-based test available to clinicians.
Read More